The Impact of Metformin on Cardiac Troponin-I and ST Resolution in Patients with ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy

Background: Thrombolytic therapy is a key in the management of ST elevated myocardial infarction (STEMI). Metformin implies a series of cardioprotective effects. We aimed to investigate how pretreatment with metformin could affect cardiac troponin I (cTnI) levels following reteplase therapy amid STE...

Full description

Bibliographic Details
Published in:	Pharmaceutical Sciences
Main Authors:	Naser Aslanabadi, Samineh Beheshtirouy, Sina Mashayekhi, Zahra Heidari, Sana Hamedani, Taher Entezari-Maleki
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2023-01-01
Subjects:	cardiac troponin i metformin stemi thrombolytic therapy
Online Access:	https://ps.tbzmed.ac.ir/PDF/ps-29-59.pdf

Similar Items

Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review
by: Junyan Zhang, et al.
Published: (2024-10-01)

Kinetics of High-Sensitive Cardiac Troponin I in Patients with ST-Segment Elevation Myocardial Infarction and Non-ST Segment Elevation Myocardial Infarction
by: Adi Haizler, et al.
Published: (2025-09-01)

Corelation Between Matrix Metalloproteinase-9 (MMP-9) And Troponin-I (cTn-I) in ST- Elevation Myocardial Infarction (STEMI) and Non ST-Elevation Acute Coronary Syndrome (NSTEACS)
by: Budi Yuli Setianto, et al.
Published: (2013-06-01)

THE DIFFERENCES IN TROPONIN I AND CK-MB VALUES IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH ST ELEVATION AND WITHOUT ST ELEVATION
by: Paulus Rio Kurniawan, et al.
Published: (2021-03-01)

Presentation, management, and outcomes of STEMI in Egypt: results from the European Society of Cardiology Registry on ST elevation myocardial infarction
by: Sameh Shaheen, et al.
Published: (2020-07-01)

Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01)

Factors Associated with Delay in Thrombolytic Therapy in Patients with ST-Elevation Myocardial Infarction
by: Shahrooz Yazdani, et al.
Published: (2012-06-01)

Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
by: Iram Shahriar, Shahina Sobhan and Ziarrat Islam
Published: (2010-12-01)

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits
by: Mohammed Hussein shaty, et al.
Published: (2019-03-01)

COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)
by: Abdullakutty Jabir, et al.
Published: (2023-07-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01)

Role of Cardiac Troponin I Level in Predicting in Hospital Outcomes in Patients with ST-segment Elevation Myocardial Infarction in Erbil-Iraq
by: Salam Naser Zangana, et al.
Published: (2018-08-01)

Role of Cardiac Troponin I Level in Predicting in Hospital Outcomes in Patients with ST-segment Elevation Myocardial Infarction in Erbil-Iraq
by: Salam Naser Zangana, et al.
Published: (2018-08-01)

Initial Results of Oral Thrombolytic Agent Clinical Application
by: Pavel Madonov, et al.
Published: (2018-07-01)

TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: N. A. Novikova, et al.
Published: (2016-01-01)

Recent trends in reperfusion in ST elevation myocardial infarction in a South Indian tier-3 city
by: Brajesh Kumar Kunwar, et al.
Published: (2012-07-01)

Spectrophotometric analysis of thrombolytic activity: SATA assay
by: Masumeh Zamanlu, et al.
Published: (2018-01-01)

Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements
by: Michaela Adamcová, et al.
Published: (1997-01-01)

Thrombolytic activity of the ethanolic extract of Vitis vinifera seeds
by: Venkatramanan Varadharajan, et al.
Published: (2015-12-01)

Thrombolytic activity of the ethanolic extract of Vitis vinifera seeds
by: Venkatramanan Varadharajan, et al.
Published: (2015-11-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

Colchicine for the Prevention of Myocardial Injury Following Elective PCI: A Randomized Clinical Trial
by: Naser Aslanabadi, et al.
Published: (2022-10-01)

Patients with ST-elevation acute myocardial infarction treated with thrombolytic therapy at the "Guillermo Domínguez López" General Teaching Hospital
by: Lilian Infantes-Velázquez, et al.
Published: (2021-03-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

Using thrombolytics in frostbite injury
by: Eric A Gross, et al.
Published: (2012-01-01)

Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction
by: Mohammad Elahimanesh, et al.
Published: (2024-02-01)

Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction
by: Jonas Henrik Kristensen, et al.
Published: (2023-10-01)

Trends in Short‐ and Long‐Term ST‐Segment–Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population‐Based ST‐Segment–Elevation Myocardial Infarction Registry
by: Cosme García‐García, et al.
Published: (2020-10-01)

The Correlation between Infarct Size and the QRS Axis Change after Thrombolytic Therapy in ST Elevation Acute Myocardial Infarction
by: M. Fatih Karakas, et al.
Published: (2012-04-01)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
by: Mehmet Yildiz, et al.
Published: (2023-06-01)

Effects of Allopurinol in the Prevention of Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Naser Aslanabadi, et al.
Published: (2024-01-01)

Evaluation of thrombolytic potential of three medicinal plants available in Bangladesh, as a potent source of thrombolytic compounds
by: Md. Ali, et al.
Published: (2014-11-01)

Validation and correlation of high-sensitive troponin I and troponin T in the emergency department
by: Moustafa. Nseir, et al.
Published: (2024-10-01)

Intravenous thrombolytic therapy in myocardial infarction (review)
by: I I Staroverov
Published: (2003-10-01)

Ticagrelor hemorrhagic safety in patients with acute coronary syndrome with ST-segment elevation received thrombolytic therapy in daily clinical practice: 30-day observation results
by: A. V. Bocharov, et al.
Published: (2020-05-01)

Relationship Between Troponin on Presentation and In‐Hospital Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Brett L. Wanamaker, et al.
Published: (2019-10-01)

Pandemic‐Related Pollution Decline and ST‐Segment‒Elevation Myocardial Infarctions
by: Sidney Aung, et al.
Published: (2022-04-01)

Age and sex-related differences in epidemiology, treatment, and mortality of patients with ST-segment elevation myocardial infarction in Iran
by: Mehdi Darabi, et al.
Published: (2023-12-01)

Impact of Metabolic Syndrome in Patients With Acute Myocardial Infarction After Thrombolytic Therapy
by: Sepas Haji Sobhani, et al.
Published: (2022-03-01)

One year Outcomes of Patients with ST-Segment Elevation Myocardial Infarction
by: Reza Heidari Moghaddam, et al.
Published: (2024-06-01)